Evaluation of the Caveolin-1 expressions in uterine cervical carcinomas

被引:1
|
作者
Degirmenci, M. [1 ]
Diniz, G. [2 ]
Kahraman, D. Solakoglu [2 ]
Sayhan, S. [2 ]
Oksuz, P. [2 ]
Ayaz, D. [2 ]
Karadeniz, T. [2 ]
Altin, Z. [3 ]
Sanci, M. [4 ]
机构
[1] Tepecik Educ & Res Hosp, Med Oncol Clin, Izmir, Turkey
[2] Tepecik Educ & Res Hosp, Pathol Lab, Izmir, Turkey
[3] Tepecik Educ & Res Hosp, Internal Med Clin, Izmir, Turkey
[4] Tepecik Educ & Res Hosp, Gynecol Oncol Clin, Izmir, Turkey
关键词
Uterine cervix; Caveolin-1 (Cav-1); Squamous cell carcinomas (SCC); Adenosquamous carcinoma; Adenocarcinoma; SQUAMOUS-CELL CARCINOMA; TUMOR; ADENOCARCINOMA; METASTASIS; REGULATOR; SURVIVAL; STROMA; EGFR;
D O I
10.12892/ejgo3655.2017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Caveolin-1 (Cav-1) is an important regulator of cellular processes and it involves several biological and metabolic functions, including cell growth, apoptosis, angiogenesis, and also carcinogenesis. This retrospective study was designed to evaluate the differences of tissue expressions of Cav-1 in a spectrum of cervical neoplasms. Materials and Methods: Tissue expression of Cav-1 was studied in a total of 107 formalin-fixed, paraffin-embedded uterine cervical tumors specimens and its association with different clinicopathologic parameters was evaluated. Results: In this series, there were 30 low- and 29 high-grade cervical intraepithelial neoplasms, 27 squamous cell carcinomas (SCCs), 15 adenosquamous carcinomas (ASCs), and six adenocarcinomas (ACs). Epithelial Cav-1 expression was determined in most SCCs, while it was negative in all ACs and most ASCs (p <0.001). Statistically it was determined that the expression of stromal Cav-1 was significantly upregulated in invasive carcinomas when compared with non-invasive squamous cell carcinomas (p <0.001), and this finding was inconsistent with literature. Conclusions: The present findings demonstrated a link between epithelial Cav-1 expression and the squamous differentiation of uterine neoplasms, as well as the relationship between invasion and stromal Cav-1 expression. Therefore it may be suggested that Cav-1 may play a role in the pathogenesis of cervical SCCs.
引用
收藏
页码:785 / 789
页数:5
相关论文
共 50 条
  • [21] Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A
    Razani, B
    Lisanti, MP
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2001, 281 (04): : C1241 - C1250
  • [22] Caveolin-1 and lipid rafts in confluent BeWo trophoblasts: Evidence for Rock-1 association with caveolin-1
    Rashid-Doubell, F.
    Tannetta, D.
    Redman, C. W. G.
    Sargent, I. L.
    Boyd, C. A. R.
    Linton, E. A.
    PLACENTA, 2007, 28 (2-3) : 139 - 151
  • [23] Effect of hereditary obesity on renal expressions of NO synthase, caveolin-1, AKt, guanylate cyclase, and calmodulin
    Li, Z
    Rodríguez-Iturbe, B
    Ni, Z
    Shahkarami, A
    Sepassi, L
    Vaziri, ND
    KIDNEY INTERNATIONAL, 2005, 68 (06) : 2766 - 2772
  • [24] CAVEOLIN-1 AND PROSTATE CANCER PROGRESSION
    Freeman, Michael R.
    Yang, Wei
    Di Vizio, Dolores
    CAVEOLINS AND CAVEOLAE: ROLES IN SIGNALING AND DISEASE MECHANISMS, 2012, 729 : 95 - 110
  • [25] Caveolae and caveolin-1 in reptilian liver
    Biazik, Joanna M.
    Jahn, Kristina A.
    Braet, Filip
    MICRON, 2011, 42 (06) : 656 - 661
  • [26] Lipid organization by the Caveolin-1 complex
    Liebl, Korbinian
    Voth, Gregory A.
    BIOPHYSICAL JOURNAL, 2024, 123 (21) : 3688 - 3697
  • [27] Tyrosine phosphorylation of caveolin-1 in the endothelium
    Aoki, T
    Nomura, R
    Fujimoto, T
    EXPERIMENTAL CELL RESEARCH, 1999, 253 (02) : 629 - 636
  • [28] Caveolin-1 expression in Schwann cells
    Mikol, DD
    Hong, HL
    Cheng, HL
    Feldman, EL
    GLIA, 1999, 27 (01) : 39 - 52
  • [29] Isoforms of caveolin-1 and caveolar structure
    Fujimoto, T
    Kogo, H
    Nomura, R
    Une, T
    JOURNAL OF CELL SCIENCE, 2000, 113 (19) : 3509 - 3517
  • [30] Is caveolin-1 a biomarker for resistance to radiotherapy?
    Cihan, Y. B.
    Tekin, B.
    ARCHIVES OF HELLENIC MEDICINE, 2020, 37 (02): : 273 - 274